Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – For assessing subsequent risk of stroke in patients who’ve had a transient ischemic attack, the so-called ABCD2 instrument is not sensitive or specific…
NEW YORK (Reuters Health) – Based on their review of screening instruments for alcohol and drug misuse, a Canadian team recommends using three quick questions in the emergency…
NEW YORK (Reuters Health) – Subcutaneous immunotherapy is at least as effective as drug therapy in controlling symptoms of seasonal allergic rhinitis, even in the first season after…
NEW YORK (Reuters Health) – Hysteroscopy using narrow-band imaging (NBI) technology may be more sensitive than white-light imaging (WLI) for diagnosing endometrial cancer and hyperplasia, hint results of…
NEW YORK (Reuters Health) – Patients with hypercholesterolemia who do not reach target lipid levels with rosuvastatin have a better change of reaching their goals by adding ezetimibe…
NEW YORK (Reuters Health) – In adults with overactive bladder and nocturia, treatment with solifenacin, may improve quality of sleep and sleep-related quality of life by decreasing the…
NEW YORK (Reuters Health) – Findings from a Swiss observational study indicate that outcomes of intravenous thrombolysis for ischemic stroke are less favorable in nonagenarians than octogenarians. Writing…
NEW YORK (Reuters Health) – A couple of extra sutures makes a difference to the clinical efficacy of a mid-urethral sling procedure for treating female stress urinary incontinence,…
NEW YORK (Reuters Health) – Results of a Mexican study indicate that 2 months of treatment with the antiinflammatory agent diacerein increases insulin secretion and improves A1C levels…
NEW YORK (Reuters Health) – A vaccine against Haemophilus influenzae and Neisseria meningitidis given to infants during their first year has an acceptable safety profile and induces protective…
